A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock-Reference-Cited by-同舟云学术

A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock

Published:2022-01 Issue: Volume:16 Page:117954682210750
ISSN:1179-5468
Container-title:Clinical Medicine Insights: Cardiology
language:en
Short-container-title:Clin Med Insights Cardiol

Author:

Shankar Aditi¹,Gurumurthy Gayathri²^ORCID,Sridharan Lakshmi³^ORCID,Gupta Divya³,Nicholson William J⁴,Jaber Wissam A⁴,Vallabhajosyula Saraschandra⁴⁵^ORCID

Affiliation:

1. Department of Medicine, Texas Health Presbyterian Hospital Dallas, Dallas, TX, USA

2. Jiva Health, Concord, CA, USA

3. Section of Heart Failure and Cardiac Transplantation, Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA

4. Section of Interventional Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA

5. Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA

Abstract

This is a focused review looking at the pharmacological support in cardiogenic shock. There are a plethora of data evaluating vasopressors and inotropes in septic shock, but the data are limited for cardiogenic shock. This review article describes in detail the pathophysiology of cardiogenic shock, the mechanism of action of different vasopressors and inotropes emphasizing their indications and potential side effects. This review article incorporates the currently used specific risk-prediction models in cardiogenic shock as well as integrates data from many trials on the use of vasopressors and inotropes. Lastly, this review seeks to discuss the future direction for vasoactive medications in cardiogenic shock.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/11795468221075064

Reference106 articles.

1. Van Diepen S, Katz JN, Albert NM, et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Lippincott Williams and Wilkins; 2017:e232-e268.

2. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery

3. Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

4. Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction

5. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tratamiento médico del shock cardiogénico;Medicina Intensiva;2024-08

2. The medical treatment of cardiogenic shock;Medicina Intensiva (English Edition);2024-08

3. Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature;International Journal of Molecular Sciences;2024-07-24

4. Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock;Journal of Cardiac Failure;2024-07

5. Cardiogenic Shock;Critical Care Nursing Quarterly;2024-06-07